HomeNDC LookupRxCUI directory › RxCUI 856886

Benzocaine 0.2 MG/MG Oral Gel [Kolorz Anesthetic] — RxCUI 856886

RxNorm drug concept · Semantic branded drug
RxCUI 856886 Semantic branded drug · SBD ● Current RxNorm concept 5 FDA products 5 package NDCs Snapshot Jul 14, 2026

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI856886
Official nameBenzocaine 0.2 MG/MG Oral Gel [Kolorz Anesthetic]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asKolorz Anesthetic 20 % Oral Gel; Kolorz Anesthetic 0.2 MG/MG Oral Gel
FDA products mapped5
Package NDCs mapped5
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

🕸️ Concept Web — How Benzocaine 0.2 MG/MG Oral Gel [Kolorz Anesthetic... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Benzocaine 0.2 MG/MG Oral Gel [Kolorz Anesthetic] RxCUI 856886

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Benzocaine 1399
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Kolorz Anesthetic 856881
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Benzocaine Oral Gel 377978
    • Benzocaine Oral Gel Product 1295107
    • Benzocaine Oral Product 1152969
    • Benzocaine Oral Gel [Kolorz Anesthetic] 856883
    • Kolorz Anesthetic Oral Gel Product 1295983
    • Kolorz Anesthetic Oral Product 1172857
    • Oral Gel 346169
    • Oral Gel Product 1294722
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Benzocaine 0.2 MG/MG Oral Gel SCD · 238910
  • Benzocaine 0.2 MG/MG SCDC · 340000
  • Benzocaine Oral Gel SCDF · 377978
  • Benzocaine Oral Gel Product SCDG · 1295107
  • Benzocaine Oral Product SCDG · 1152969

Brand-Name Concepts

  • Benzocaine 0.2 MG/MG [Kolorz Anesthetic] SBDC · 856885
  • Benzocaine Oral Gel [Kolorz Anesthetic] SBDF · 856883
  • Kolorz Anesthetic Oral Gel Product SBDG · 1295983
  • Kolorz Anesthetic Oral Product SBDG · 1172857
  • Kolorz Anesthetic BN · 856881

📦 FDA Products & Package NDCs

5 products · 5 package NDCs
5 package NDCs map to RxCUI 856886 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
25047-0751-01 29.6 g in 1 BOTTLE (25047-751-01) KOLORZ TOPICAL ANESTHETIC TRIPLE MINT DMG AMERICA, LLC 2019-09-06
25047-0752-01 29.6 g in 1 BOTTLE (25047-752-01) KOLORZ TOPICAL ANESTHETIC CHERRY BURST DMG AMERICA, LLC 2019-09-06
25047-0753-01 29.6 g in 1 BOTTLE (25047-753-01) KOLORZ TOPICAL ANESTHETIC COTTON CANDY DMG AMERICA, LLC 2019-09-06
25047-0754-01 29.6 g in 1 BOTTLE (25047-754-01) KOLORZ TOPICAL ANESTHETIC BLUE RASBERRY DMG AMERICA, LLC 2019-09-06
25047-0755-01 29.6 g in 1 BOTTLE (25047-755-01) KOLORZ TOPICAL ANESTHETIC PINA COLADA DMG AMERICA, LLC 2019-09-06
Observed labelers: DMG AMERICA, LLC (5) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.